These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1119 related articles for article (PubMed ID: 22270953)

  • 1. Targeting MET in cancer: rationale and progress.
    Gherardi E; Birchmeier W; Birchmeier C; Vande Woude G
    Nat Rev Cancer; 2012 Jan; 12(2):89-103. PubMed ID: 22270953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signalling by HGF/SF and Met: the role of heparan sulphate co-receptors.
    Kemp LE; Mulloy B; Gherardi E
    Biochem Soc Trans; 2006 Jun; 34(Pt 3):414-7. PubMed ID: 16709175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of hepatocyte growth factor/scatter factor and its receptor c-Met in brain tumors: evidence for a role in progression of astrocytic tumors (Review).
    Moriyama T; Kataoka H; Koono M; Wakisaka S
    Int J Mol Med; 1999 May; 3(5):531-6. PubMed ID: 10202187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel recombinant soluble splice variant of Met is a potent antagonist of the hepatocyte growth factor/scatter factor-Met pathway.
    Tiran Z; Oren A; Hermesh C; Rotman G; Levine Z; Amitai H; Handelsman T; Beiman M; Chen A; Landesman-Milo D; Dassa L; Peres Y; Koifman C; Glezer S; Vidal-Finkelstein R; Bahat K; Pergam T; Israel C; Horev J; Tsarfaty I; Ayalon-Soffer M
    Clin Cancer Res; 2008 Jul; 14(14):4612-21. PubMed ID: 18628476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene of the month: MET.
    Skead G; Govender D
    J Clin Pathol; 2015 Jun; 68(6):405-9. PubMed ID: 25987653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocyte growth factor/MET in cancer progression and biomarker discovery.
    Matsumoto K; Umitsu M; De Silva DM; Roy A; Bottaro DP
    Cancer Sci; 2017 Mar; 108(3):296-307. PubMed ID: 28064454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression.
    Abounader R; Ranganathan S; Lal B; Fielding K; Book A; Dietz H; Burger P; Laterra J
    J Natl Cancer Inst; 1999 Sep; 91(18):1548-56. PubMed ID: 10491431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent and selective inhibitors of the Met [hepatocyte growth factor/scatter factor (HGF/SF) receptor] tyrosine kinase block HGF/SF-induced tumor cell growth and invasion.
    Wang X; Le P; Liang C; Chan J; Kiewlich D; Miller T; Harris D; Sun L; Rice A; Vasile S; Blake RA; Howlett AR; Patel N; McMahon G; Lipson KE
    Mol Cancer Ther; 2003 Nov; 2(11):1085-92. PubMed ID: 14617781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential therapeutic and prognostic impacts of the c-MET/HGF signaling pathway in colorectal cancer.
    Parizadeh SM; Jafarzadeh-Esfehani R; Fazilat-Panah D; Hassanian SM; Shahidsales S; Khazaei M; Parizadeh SMR; Ghayour-Mobarhan M; Ferns GA; Avan A
    IUBMB Life; 2019 Jul; 71(7):802-811. PubMed ID: 31116909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer.
    Toiyama Y; Yasuda H; Saigusa S; Matushita K; Fujikawa H; Tanaka K; Mohri Y; Inoue Y; Goel A; Kusunoki M
    Int J Cancer; 2012 Jun; 130(12):2912-21. PubMed ID: 21796631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention.
    Christensen JG; Burrows J; Salgia R
    Cancer Lett; 2005 Jul; 225(1):1-26. PubMed ID: 15922853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene of the month: HGF.
    Fajardo-Puerta AB; Mato Prado M; Frampton AE; Jiao LR
    J Clin Pathol; 2016 Jul; 69(7):575-9. PubMed ID: 27072686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the hepatocyte growth factor/Met pathway in cancer.
    De Silva DM; Roy A; Kato T; Cecchi F; Lee YH; Matsumoto K; Bottaro DP
    Biochem Soc Trans; 2017 Aug; 45(4):855-870. PubMed ID: 28673936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HGF/c-MET pathway in cancer: from molecular characterization to clinical evidence.
    Fu J; Su X; Li Z; Deng L; Liu X; Feng X; Peng J
    Oncogene; 2021 Jul; 40(28):4625-4651. PubMed ID: 34145400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scatter factor/hepatocyte growth factor protects against cytotoxic death in human glioblastoma via phosphatidylinositol 3-kinase- and AKT-dependent pathways.
    Bowers DC; Fan S; Walter KA; Abounader R; Williams JA; Rosen EM; Laterra J
    Cancer Res; 2000 Aug; 60(15):4277-83. PubMed ID: 10945642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developing Antagonists for the Met-HGF/SF Protein-Protein Interaction Using a Fragment-Based Approach.
    Winter A; Sigurdardottir AG; DiCara D; Valenti G; Blundell TL; Gherardi E
    Mol Cancer Ther; 2016 Jan; 15(1):3-14. PubMed ID: 26712116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of hepatocyte growth factor/scatter factor and met receptor signaling in hair follicle morphogenesis and cycling.
    Lindner G; Menrad A; Gherardi E; Merlino G; Welker P; Handjiski B; Roloff B; Paus R
    FASEB J; 2000 Feb; 14(2):319-32. PubMed ID: 10657988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The roles of hepatocyte growth factor/scatter factor and met receptor in human cancers (Review).
    To CT; Tsao MS
    Oncol Rep; 1998; 5(5):1013-24. PubMed ID: 9683803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte growth factor/scatter factor and its receptor c-Met are overexpressed and associated with an increased microvessel density in malignant pleural mesothelioma.
    Tolnay E; Kuhnen C; Wiethege T; König JE; Voss B; Müller KM
    J Cancer Res Clin Oncol; 1998; 124(6):291-6. PubMed ID: 9692834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells.
    Weidner KM; Sachs M; Birchmeier W
    J Cell Biol; 1993 Apr; 121(1):145-54. PubMed ID: 8384622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.